- Home
- ECOR vs FLL Comparison
ECOR vs FLL Comparison
Compare ECOR & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECOR | FLL |
|---|---|---|
| Founded | 2005 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.6M | 77.7M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ECOR | FLL |
|---|---|---|
| Price | $9.50 | $1.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $18.00 | $4.00 |
| AVG Volume (30 Days) | 95.4K | ★ 126.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.45 |
| EPS | N/A | ★ N/A |
| Revenue | $32,032,000.00 | ★ $302,376,000.00 |
| Revenue This Year | $33.60 | $7.54 |
| Revenue Next Year | $30.40 | $6.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.20 | 3.53 |
| 52 Week Low | $4.41 | $1.96 |
| 52 Week High | $10.95 | $3.61 |
Technical Indicators
Market Signals| Indicator | ECOR | FLL |
|---|---|---|
| Relative Strength Index (RSI) | 56.76 | 38.17 |
| Support Level | $5.70 | $1.99 |
| Resistance Level | $10.60 | $2.74 |
| Average True Range (ATR) | 0.80 | 0.12 |
| MACD | -0.14 | -0.00 |
| Stochastic Oscillator | 43.30 | 11.11 |
Price Performance
Historical ComparisonAbout ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
About FLL Full House Resorts Inc.
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins. Geographically, it operates in United States.